Addiction to Diazepam

References

• Aivazian G. H. Clinical evaluation of diazepam. Dis. Nerv. Syst 1964; 25: 491–495
   PubMedGoogle Scholar
• Anonymous. Meprobamate. Med. Lett. Drugs Ther 1959; 1: 3–4
   Google Scholar
• Anonymous. A Study of Health Practices and Opinions. National Analysts Inc., for the Food and Drug Administration, Washington, DC 1972, conducted by
   Google Scholar
• Arneson G. E. The risks of the new psychotropic drugs. J. La. State Med. Soc 1961; 113: 372–376
   Google Scholar
• Bandura A. Principles of Behavior Modification. Holt, Rinehart and Winston, New York 1969; 485–486
   Google Scholar
• Barten H. H. Toxic psychosis with transient dysmnesic syndrome following withdrawal from Valium. Am. J. Psychiatry 1965; 122: 1210–1211
   Google Scholar
• Bartholomew A. A. Amphetamine addiction. Med. J. Aust 1970; 1: 1209–1214
   PubMedGoogle Scholar
• Bowes H. A. The role of diazepam (Valium) in emotional illness. Psychosomatics 1965; 6: 336–340
   PubMed Web of Science ®Google Scholar
• Burdine W. E. Diazepam in a general psychiatric practice. Am. J. Psychiatry 1964; 121: 589–592
   PubMedGoogle Scholar
• Burnett R. E., Holman R. E. Experience with Valium in general practice. Med. Times 1965; 65: 36–41
   Google Scholar
• Chesrow E. J., Kaplitz S. E., Breme J. T., Nusci J., Sabatin R. W. The use of Valium in the chronically ill and in the disturbed elderly patient. J. Am. Geriatr. Soc 1962; 10: 667–671
   PubMed Web of Science ®Google Scholar
• Clare A. W. Diazepam, alcohol, and barbiturate abuse. Br. Med. J 1971; 4: 340
   PubMed Web of Science ®Google Scholar
• Constant G. A. Preliminary report on the use of a new agent in depression and tension statements. Dis. Nerv. Syst 1960; 21: 37
   PubMedGoogle Scholar
• Constant G. A., Gruver F. A. Preliminary evaluation of diazepam in psychiatric disorders. Psychosomatics 1963; 80–84
   PubMedGoogle Scholar
• Cromwell H. A. A psychosomatic approach to internal medicine. Colo. GP 1963; 2: 6–11, a
   Google Scholar
• Cromwell H. A. Controlled evaluation of psychotherapeutic drugs in internal medicine. Clin. Med 1963; 70: 2239–2244, b
   Google Scholar
• Domino E. F. Human pharmacology of tranquilizing drugs. Clin. Pharmacol Ther 1962; 3: 599–664
   PubMed Web of Science ®Google Scholar
• Dorfman W. Recent advances in psychopharmacology. Dis. Nerv. Syst 1963; 24: 693–694
   Google Scholar
• Dorfran W. Some experiences in “total” treatment of patients with emotional illness. Psychosomatics 1964; 5: 351–354
   PubMedGoogle Scholar
• Edgley R. Diazepam, nitrazepam and the N. H. S. Med. J. Aust 1970; 33: 297–298
   Google Scholar
• Essig C. F. Addiction to nonbarbiturate sedative and tranquilizing drugs. Clin. Pharmacol. Ther 1964; 5: 334, 343
   Google Scholar
• Feldman P. E. An analysis of the efficacy of diazepam. J. Neuropsychiatry 1962; 3: 562, (Suppl. 1)
   Google Scholar
• Findley J. D., Robinson W. W., Peregrino L. Addiction to secobarbital and chlordiazepoxide in the rhesus monkey by means of a self-infusion preference procedure. Psychopharmacologia (Berl) 1972; 26: 93–114
   PubMedGoogle Scholar
• Fowlkes E. W., Strickland D. A., Peirson G. A. Control of spastic states in neurological patients with diazepam. Am. J. Phys. Med 1964; 44: 9–19
   Google Scholar
• Grayson L. D. A new psychotherapeutic drug used in dermatology. Gen. Pract 1962; 25: 9–11
   Google Scholar
• Haizlip T. M., Ewing J. A. Meprobamate habituation. N. Engl. J. Med 1958; 258: 1181–1186
   PubMedGoogle Scholar
• Hollister L. E., Bennett J. L., Kimbell I., Savage C., Overall J. E. Diazepam in newly admitted schizophrenics. Dis. Nerv. Syst 1963; 24: 746–749
   PubMedGoogle Scholar
• Hollister L. E., Motzenbacker F. P., Degan R. O. Withdrawal reactions from chlordiazepoxide (“Librium”). Psychopharmacologia (Berl) 1961; 2: 63–68
   Google Scholar
• Katz R. A., Aldes J. H., Rector M. A. A new approach to muscle relaxation. J. Neuropsychiatry 1962; 3: 91–95
   Google Scholar
• Kelley J. W. A new pharmacological agent for the management of psychiatric disorders. Clin. Med 1962; 69: 1789–1790, a
   Google Scholar
• Kelley J. W. Management of psychiatric disorders with diazepam. Clin. Med 1962; 69: 122–129, b
   Google Scholar
• Kerry R. J., Jenner F. A. A double blind crossover comparison of diazepam (Valium RO 5–2807) with chlordiazepoxide (Librium) in the treatment of neurotic anxiety. Psychopharmacologia (Berl) 1962; 3: 302–306
   Google Scholar
• Klerman G. L. Drugs and social values. Int. J. Addict 1970; 5: 312–319
   Google Scholar
• Lawrence F. E. Chlordiazepoxide in the treatment of alcoholism. J. Neuropsychiatry 1960; 2: 93–100
   PubMedGoogle Scholar
• Levy S. W. A psychosomatic approach to the management of recalcitrant dermatoses. Psychosomatics 1963; 4: 334–337
   PubMedGoogle Scholar
• Love J. Diazepam in treatment of emotional disorders. Dis. Nerv. Syst 1963; 24: 693–694
   Google Scholar
• Mackinnon A. V. Favorite prescriptions in general practice. Practitioner 1967; 198: 80–84
   PubMedGoogle Scholar
• McGovern J. P., Haywood T. J., Thomas O. C., Fernandez A. A. Studies with a benzodiazepine derivative in various allergic diseases. Psychosomatics 1963; 4: 203–211
   Google Scholar
• Mellinger G. D., Balter M. B., Manheimer D. I. Patterns of psychotherapeutic drug use among adults in San Francisco. Arch. Gen. Psychiatry 1971; 25: 389–394
   Google Scholar
• Merliss W. J., Krumholz W. A. Double-blind comparison of diazepam-chlordiazepoxide and chlorpromazine in psychotic patients. J. Neuropsychiatry 1962; 3: 562, (Suppl. 1)
   Google Scholar
• Moore S. F., Jr. Therapy of psychosomatic symptoms in gynecology: An evaluation of chlordiazepoxide. Curr. Ther. Res 1962; 4: 249–257
   PubMedGoogle Scholar
• Parry H. J., Balter M. B., Mellinger G. D., Cisin I. H., Manheimer D. I. National patterns of psychotherapeutic drug use. Arch. Gen. Psychiatry 1973; 28: 769–783
   Web of Science ®Google Scholar
• Phillips R. M., Judy F. R., Judy H. E. Meprobamate addiction. Northwest Med 1957; 56: 453–454
   PubMedGoogle Scholar
• Pignataro F. P. Experience with chemotherapy in refractory psychiatric disorders. Curr. Ther. Res 1962; 4: 389–398
   PubMedGoogle Scholar
• Proctor R. C. The improved management of incapacitating anxiety states. J. Neuropsychiatry 1962; 3: 151–154
   Google Scholar
• Randall L. O., Heise G. A., Schallek W., Bagdar R. E., Banziger R., Boris A., Moe R. A., Abrams W. B. Pharmacological and clinical studies on Valium, a new psychotherapeutic agent of the benzodiazepine class. Curr. Ther. Res 1961; 3: 405–425
   PubMed Web of Science ®Google Scholar
• Rathbone R. The role of a psychotherapeutic drug in internal medicine, a controlled evaluation in private practice. Med. Times 1963; 91: 1186–1192
   PubMedGoogle Scholar
• Ryan R. E. Myalgia of the head and its treatment with diazepam. Headache 1963; 3: 63–65
   PubMedGoogle Scholar
• Schuster C. R., Thompson T. Self-administration of and behavioral dependence on drugs. An. Res. Pharmacol 1969; 9: 483–502
   Google Scholar
• Smart R. G., Fejer D. Drug use among adolescents and their parents; closing the generation gap in mood modification. J. Abnorm. Psychol 1972; 79: 153–160
   PubMed Web of Science ®Google Scholar
• Susses J. N., Linton P. A., Herlihy C. E. Anxiety and depression in borderline schizophrenic states—treatment with Valium, a Librium analog. Psychosomatics 1961; 2: 256–260
   Google Scholar
• Tudo I. Valium treatment in status epilepticus. Electroencephalogram Clin. Neurophysiol 1971; 30: 365–367
   Google Scholar
• Williams M. W. Clinical impressions on the use and value of chlordiazepoxide in psychiatric practice. South. Med. J 1961; 54: 922–926
   PubMedGoogle Scholar